now can you get our hands on that abstract? I guess I can wait to have Dr. Shapiro tell the world about it, the best thing to happen to the oncology world since discovery of the guardian angle genome - which would be activation and repair of the guardian angle genome. The time is approaching - THE CORPORATION OF 2013 - CELLCEUTIX, and it's publicly traded!